Network methods and design of randomized trials: Application to investigation of COVID-19 vaccination boosters.
- Published in:
- Clinical Trials, 2022, v. 19, n. 4, p. 363, doi. 10.1177/17407745221111818
- By:
- Publication type:
- Article
Works matching IS 17407745 AND DT 2022 AND VI 19 AND IP 4
Results: 15
1
2
Thirteenth annual UPenn conference on statistical issues in clinical trials: Cluster-randomized clinical trials—opportunities and challenges (afternoon panel session).
- Published in:
- Clinical Trials, 2022, v. 19, n. 4, p. 422, doi. 10.1177/17407745221101284
- By:
- Publication type:
- Article
3
Thirteenth annual UPenn conference on statistical issues in clinical trials: Cluster randomized clinical trials—opportunities and challenges (morning panel session).
- Published in:
- Clinical Trials, 2022, v. 19, n. 4, p. 384, doi. 10.1177/17407745221101267
- By:
- Publication type:
- Article
4
Proceedings of the University of Pennsylvania 13th annual conference on statistical issues in clinical trials: Cluster randomized clinical trials—Challenges and opportunities.
- Published in:
- Clinical Trials, 2022, v. 19, n. 4, p. 351, doi. 10.1177/17407745221100226
- By:
- Publication type:
- Article
5
An introduction to spillover effects in cluster randomized trials with noncompliance.
- Published in:
- Clinical Trials, 2022, v. 19, n. 4, p. 375, doi. 10.1177/17407745221093580
- By:
- Publication type:
- Article
6
Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficiently.
- Published in:
- Clinical Trials, 2022, v. 19, n. 4, p. 432, doi. 10.1177/17407745221093577
- By:
- Publication type:
- Article
7
Reporting of clinical trial safety results in ClinicalTrials.gov for FDA-approved drugs: A cross-sectional analysis.
- Published in:
- Clinical Trials, 2022, v. 19, n. 4, p. 442, doi. 10.1177/17407745221093567
- By:
- Publication type:
- Article
8
Barriers and enablers to cancer clinical trial participation and initiatives to improve opportunities for rural cancer patients: A scoping review.
- Published in:
- Clinical Trials, 2022, v. 19, n. 4, p. 464, doi. 10.1177/17407745221090733
- By:
- Publication type:
- Article
9
Current recommendations/practices for anonymising data from clinical trials in order to make it available for sharing: A scoping review.
- Published in:
- Clinical Trials, 2022, v. 19, n. 4, p. 452, doi. 10.1177/17407745221087469
- By:
- Publication type:
- Article
10
Practical issues in operationalizing the design and outcome evaluation of cluster randomized trials.
- Published in:
- Clinical Trials, 2022, v. 19, n. 4, p. 407, doi. 10.1177/17407745221087465
- By:
- Publication type:
- Article
11
Random effect misspecification in stepped wedge designs.
- Published in:
- Clinical Trials, 2022, v. 19, n. 4, p. 380, doi. 10.1177/17407745221084702
- By:
- Publication type:
- Article
12
Randomization: Beyond the closurization principle.
- Published in:
- Clinical Trials, 2022, v. 19, n. 4, p. 396, doi. 10.1177/17407745221080714
- By:
- Publication type:
- Article
13
The ring vaccination trial design for the estimation of vaccine efficacy and effectiveness during infectious disease outbreaks.
- Published in:
- Clinical Trials, 2022, v. 19, n. 4, p. 402, doi. 10.1177/17407745211073594
- By:
- Publication type:
- Article
14
Practical considerations in utilizing cluster randomized controlled trials conducted in biopharmaceutical industry.
- Published in:
- Clinical Trials, 2022, v. 19, n. 4, p. 416, doi. 10.1177/17407745211073484
- By:
- Publication type:
- Article
15
Influential methods reports for group-randomized trials and related designs.
- Published in:
- Clinical Trials, 2022, v. 19, n. 4, p. 353, doi. 10.1177/17407745211063423
- By:
- Publication type:
- Article